The world’s most valuable biological inputs startups
Companies that make biological and bio-based inputs for crops: microbial fertilisers and biostimulants, biopesticides and biofungicides (microbes, peptides, RNA, proteins), pheromones and other natural signals for pest control, and beneficial insects. Ranked worldwide by AI-estimated valuation, with listed pure players shown in grey at their market value for reference. The market sets the value; our AI estimates it.
Key metrics for this segment: key milestone. Figures as published by each company or the press, dated, not recalculated. The AIs weigh them alongside funding history and comparables.
Not in this segment. Listed, so not ranked: Biotalys (shown in grey), Bioceres Crop Solutions and Vittia, whose biologicals sit beside other crop inputs, Amoéba, Eden Research, Save Foods and Bee Vectoring. Bought by a group: Symborg (Corteva), BioPhero (FMC), Biotrop (BioFirst), Ceradis (Gowan), Plant Health Care (PI Industries), Marrone Bio (Bioceres), AgBiome (assets sold). Created by a group or owned by a family without outside investors: Koppert, Andermatt, Agrauxine (Lesaffre), Lavie Bio (Evogene), Suterra, Rizobacter, IPL Biologicals, ENAI (launched by Indigo Ag). Closed: Joyn Bio. In other segments: soil carbon programmes (Indigo Ag, Loam Bio) under Carbon credits, soil analytics and sensors (Biome Makers, Trace Genomics, Pattern Ag, Semios) under Precision farming; crop-protection chemistry discovered with AI (Enko, Moa Technology), plant genetics (Cibus, Ohalo), animal health and multi-industry fermentation (Locus Fermentation Solutions) are outside this segment. Chinese companies (Moon Biotech) are never ranked. A company appears in one segment only. Method
Rankings by region
Filter the ranking and the Radar. Ranks stay worldwide. Regional pages: Asia · Europe · Latin America & Caribbean · Middle East & North Africa · North America.World · 32 ranked companies
| # | Company | Last round · Key metrics | Estimated valuation (AI) · range | Pool of interestsInterest: a free, non-binding declaration on a company, or on a sector within an area, made during the free phase of a pool. Pool: all the Interests declared on the same target. This column shows the number of Backers and the combined amount of their tickets. Terms for Backers → | BackBacking a startup on Uback (pronounced “you back”) can be done in two ways: Interest · free: a non-binding declaration that signals your demand for a company or a sector. You can move or withdraw it at any time, with up to 5 at once. Intention · coming soon: a paid, confirmed declaration, still non-binding. Once its pool reaches critical mass, it is presented to a company by a local partner. Neither is an order nor a commitment to invest. Terms for Backers → |
|---|---|---|---|---|---|
| 1 | BioFirstBelgium · Europe · Controlled by Floridienne | Capital increase · USD 428M · Sep 2023Acquired 85% of Brazil's Biotrop (2023 sales ~EUR 125M) · Dec 2023 | Last known equity round: Capital increase · USD 428M · Sep 2023 (Sofina, Tikehau Capital, M&G, Unigrains, Sofiprotéol); about EUR 400M, financing the purchase of BiotropMethod | — | Back |
| 2 | Pivot BioUnited States · North America | Series D · USD 430M · Jul 2021Revenue passed USD 100M in 2023 · 2023 | Last known equity round: Series D · USD 430M · Jul 2021 (DCVC, Temasek; Breakthrough Energy Ventures, Bill & Melinda Gates Foundation)Method | — | Back |
| 3 | Sound AgricultureUnited States · North America | Series D · USD 100M · Dec 2024Products used on about 2 million US acres · Dec 2024 | Last known equity round: Series D · USD 100M · Dec 2024 (BMO Impact Investment Fund, S2G Ventures); USD 75M in 2022 plus a USD 25M extensionMethod | — | Back |
| 4 | VestaronUnited States · North America | Series C · USD 92M · Aug 2022Spear peptide products (Spear-T, Spear-Lep) registered and sold in the US · Aug 2022 | Last known equity round: Series C · USD 92M · Aug 2022 (Ordway Selections, Cavallo Ventures; Novo Holdings, Syngenta Ventures, Fortistar); USD 82M plus a USD 10M extensionMethod | — | Back |
| 5 | Invaio SciencesUnited States · North America · Controlled by Flagship Pioneering (creator and lead investor) | Series C · USD 88.9M · May 2021Partnership with Brazil's Fundecitrus against citrus greening · Jan 2026 | Last known equity round: Series C · USD 88.9M · May 2021 (Flagship Pioneering; Stage 1 Ventures, Bluwave Capital, Alexandria Venture Investments)Method | — | Back |
| 6 | Aphea.BioBelgium · Europe | Series C · USD 77M · Jul 2023First biostimulant seed treatment ΛCTIV launched commercially in Europe · Jul 2023 | Last known equity round: Series C · USD 77M · Jul 2023 (Innovation Industries; Korys, Bill & Melinda Gates Foundation, SFPIM, ECBF, Astanor); EUR 70MMethod | — | Back |
| 7 | SuperbacBrazil · Latin America & Caribbean | Private equity (minority) · USD 62.5M · Jul 2023Key metrics not disclosed | Last known equity round: Private equity (minority) · USD 62.5M · Jul 2023 (XP Private Equity); BRL 300M for about 30%Method | — | Back |
| 8 | Elicit PlantFrance · Europe | Series B · USD 47.7M · Nov 2024Biostimulants applied on more than 500,000 hectares of crops · Nov 2024 | Last known equity round: Series B · USD 47.7M · Nov 2024 (Carbyne Equity Partners; Sofinnova Partners, ECBF, Bpifrance (Ecotechnologies 2)); EUR 45MMethod | — | Back |
| 9 | NewLeaf SymbioticsUnited States · North America | Series D · USD 45M · Dec 2023Products used on about 3.5 million acres in 2023 · Dec 2023 | Last known equity round: Series D · USD 45M · Dec 2023 (Gullspang Re:food; Otter Capital, S2G Ventures, Leaps by Bayer)Method | — | Back |
| 10 | MicropepFrance · Europe | Series B · USD 40M · Sep 2024Collaborations with R&D, manufacturing and distribution partners incl. Corteva · Sep 2024 | Last known equity round: Series B · USD 40M · Sep 2024 (Corteva Catalyst, Sparkfood; existing investors); USD 29M plus an USD 11M extensionMethod | — | Back |
| 11 | AgroSpheresUnited States · North America | Series B · USD 37M · Sep 2024EPA approval of first AgriCell-powered biofungicide · Sep 2024 | Last known equity round: Series B · USD 37M · Sep 2024 (Zebra Impact Ventures; Lewis and Clark AgriFood, Ospraie Ag Science, FMC Ventures, BIDRA, Cavallo)Method | — | Back |
| 12 | AgrivalleBrazil · Latin America & Caribbean · Controlled by 10b | Growth equity · USD 30.8M · Jul 20202025 sales volume up 25%; 2026 revenue growth guided at 10-15% · Mar 2026 | Last known equity round: Growth equity · USD 30.8M · Jul 2020 (Tarpon); BRL 160MMethod | — | Back |
| 13 | GreenLight BiosciencesUnited States · North America · Controlled by a consortium led by Fall Line Capital | Series C · USD 25M · Mar 2025Calantha RNA spray registered in the US and Ukraine for potato growers · Apr 2025 | Last known equity round: Series C · USD 25M · Mar 2025 (Just Climate)Method | — | Back |
| — | BiotalysBelgium · Listed · Euronext Brussels · BTLS | Product revenue none in H1 2026Private placement EUR 12.05M from existing investors, May 2026 | about USD 105MMarket cap · Oct 2026Listed company · not ranked | ||
| 14 | SolubioBrazil · Latin America & Caribbean · Controlled by Aqua Capital | Growth equity · USD 19.8M · Apr 2024BRL 206M revenue in 2023; targets BRL 1bn within five years · Apr 2024 | Last known equity round: Growth equity · USD 19.8M · Apr 2024 (Aqua Capital); BRL 100M, partly buying out former partnersMethod | — | Back |
| 15 | MycophytoFrance · Europe | Series A · USD 18.7M · Jan 2026Expanding to Spain and Morocco, new markets Côte d'Ivoire and Benelux · Jan 2026 | Last known equity round: Series A · USD 18.7M · Jan 2026 (Innovacom, BNP Paribas, Bpifrance Deep Tech 2030; CDG Invest, Noshaq, RSI, Crédit Agricole); EUR 16MMethod | — | Back |
| 16 | AgriodorFrance · Europe | Series A · USD 17.1M · Apr 2026First sugar beet aphid product distributed under exclusive deal with Syngenta · Apr 2026 | Last known equity round: Series A · USD 17.1M · Apr 2026 (Crédit Mutuel Impact; Région Sud Investissement, Capagro, SWEN Capital Partners); EUR 15MMethod | — | Back |
| 17 | Pluton BiosciencesUnited States · North America | Series A · USD 16.5M · May 2023Key metrics not disclosed | Last known equity round: Series A · USD 16.5M · May 2023 (Illumina Ventures, RA Capital; Fall Line Capital, Grantham Foundation)Method | — | Back |
| 18 | BioConsortiaUnited States · North America · Controlled by Otter Capital and affiliated funds (lead, long-standing investors) | Financing round · USD 15M · Aug 2025Always-N nitrogen seed treatment launched in New Zealand in 2024; Mosaic partner for Americas · Aug 2025 | Last known equity round: Financing round · USD 15M · Aug 2025 (Otter Capital and affiliated funds); existing investors; split between equity and debt not statedMethod | — | Back |
| 19 | Solasta BioUnited Kingdom · Europe | Series A · USD 14M · Sep 20242023 field trials performed as well as or better than standard insecticides (company) · 2023 | Last known equity round: Series A · USD 14M · Sep 2024 (Forbion, FMC Ventures, Corteva Catalyst; Cavallo Ventures, Scottish Enterprise); GBP 10.7MMethod | — | Back |
| 20 | FytekoBelgium · Europe | Series B · USD 13.5M · Feb 2025Biostimulants sold to major seed and plant-nutrition companies since 2022 · Feb 2025 | Last known equity round: Series B · USD 13.5M · Feb 2025 (Crédit Mutuel Impact; SFPIM, Supernova Invest, IMBC, finance&invest.brussels, existing shareholders); EUR 13MMethod | — | Back |
| 21 | GenicaBrazil · Latin America & Caribbean | Series C · USD 12.5M · Jun 20242025 revenue above BRL 200M (+~30%); 2026 budget BRL 300M · Jan 2026 | Last known equity round: Series C · USD 12.5M · Jun 2024 (Mitsubishi Corporation (lead); SP Ventures, Vox Capital); BRL 68MMethod | — | Back |
| 22 | Ascribe BioUnited States · North America | Series A · USD 12M · Oct 2025First regulatory approval of Phytalix biofungicide expected in Brazil · Oct 2025 | Last known equity round: Series A · USD 12M · Oct 2025 (Acre Venture Partners, Corteva Catalyst; Syngenta Group Ventures, Trailhead Capital)Method | — | Back |
| 23 | Toopi OrganicsFrance · Europe | Series A · USD 11.8M · Sep 2023Lactopi Start authorised for sale in six EU countries · 2022 | Last known equity round: Series A · USD 11.8M · Sep 2023 (VisVires New Protein; Edaphon, MAIF Impact, BNP Paribas Développement); EUR 11M equity at ~1.07 USD/EUR (Sept 2023); total EUR 16M incl. ~EUR 5M non-dilutive excludedMethod | — | Back |
| 24 | Groundwork BioAgIsrael · Middle East & North Africa | Funding round · USD 11M · May 2021Inoculants used on about 1 million acres · 2021 | Last known equity round: Funding round · USD 11M · May 2021 (Ibex Investors; ProDelta, Future Foodways)Method | — | Back |
| 25 | Harpe Bioherbicide SolutionsUnited States · North America | Funding round · USD 10.5M · Apr 2023Key metrics not disclosed | Last known equity round: Funding round · USD 10.5M · Apr 2023 (ADM; iSelect, Alexandria Venture Investments)Method | — | Back |
| 26 | Sea6 EnergyIndia · Asia | Series B · USD 9M · Jul 2021Key metrics not disclosed | Last known equity round: Series B · USD 9M · Jul 2021 (Aqua-Spark (lead); Silverstrand Capital); USD 9M as reported.Method | — | Back |
| 27 | ArevoSweden · Europe | Series A · USD 8.5M · Oct 2025Launched bio-based lawn fertiliser; moving to industrial-scale production · Oct 2025 | Last known equity round: Series A · USD 8.5M · Oct 2025 (Industrifonden, Fort Knox, Navigare Ventures, Stora Enso); EUR 7.3MMethod | — | Back |
| 28 | FA BioUnited Kingdom · Europe | Funding round · USD 6.7M · Feb 2024Key metrics not disclosed | Last known equity round: Funding round · USD 6.7M · Feb 2024 (Clean Growth Fund, Pymwymic; Ship2B Ventures); GBP 5.3MMethod | — | Back |
| 29 | BioPrime AgriSolutionsIndia · Asia | Series A · USD 6M · Oct 2024BioNexus platform identified 170+ novel strains from a library of ~18,000 · Oct 2024 | Last known equity round: Series A · USD 6M · Oct 2024 (Edaphon (lead); Omnivore, Inflexor Ventures); USD 6M as reported.Method | — | Back |
| 30 | Immunrise BiocontrolFrance · Europe | Funding round · USD 5.1M · Aug 2022Key metrics not disclosed | Last known equity round: Funding round · USD 5.1M · Aug 2022 (Baron Philippe de Rothschild group, De Sangosse); EUR 5MMethod | — | Back |
| 31 | Evologic TechnologiesAustria · Europe | Funding round · USD 3M · Feb 2021Fermentation plant in Vienna serving international customers · Feb 2021 | Last known equity round: Funding round · USD 3M · Feb 2021 (ASKUR Invest; RWA, BayWa, Mauthner, Vivida); EUR 2.5MMethod | — | Back |
| 32 | WAKUJapan · Asia | Pre-Series A · USD 2.2M · Aug 2026Key metrics not disclosed | Last known equity round: Pre-Series A · USD 2.2M · Aug 2026 (Chugin Capital Partners, Asahi Media Lab Ventures, Nanto Capital Partners, Tottori Capital); JPY 330M; bank loans not countedMethod | — | Back |
Back · Declaring an intention does not mean this company is raising funds. · Terms
Corporate investor? Back the startups of your own segment
No ranked company in this region yet: see the Radar.
Get every new edition
New entries, exits and movements, twice a year.
How to read this ranking
Rank
Companies are ranked by AI-estimated valuation, highest first. The market sets the value; our AI estimates it.
Estimate
An AI-estimated valuation, its uncertainty range and its order of magnitude. Indicative, and imperfect by nature.
- Hundreds of k$
- Millions $
- Tens of M$
- Hundreds of M$
- Unicorn
- Decacorn
- Hectocorn
Challengers
A registered company raising funds that is not in the ranking will be able, for a fee, to appear in a separate list labelled “Challengers”, for a set period, with a memo available to verified Backers. The listing has no effect on the ranking. Not open yet.
Radar · known eligible companies, not ranked
Sorted by date of last round, with no judgement and no AI call.
- Robigo · United States · North AmericaSep 2026; amount undisclosedBack
- Kimitec · Spain · EuropeJul 2026; amount undisclosedBack
- Kula Bio · United States · North AmericaNov 2025; amount undisclosedBack
- Symbiomics · Brazil · Latin America & CaribbeanJun 2025; amount undisclosedBack
- Puna Bio · Argentina · Latin America & CaribbeanApr 2025; amount undisclosedBack
- Jord BioScience · United States · North AmericaFeb 2025; amount undisclosedBack
- Antofenol · France · EuropeMay 2022; amount undisclosedBack
- Azotic Technologies · United Kingdom · EuropeJul 2021; amount undisclosedBack
- AgroSustain · Switzerland · EuropeJul 2021; CHF 4.8M including an EU grantBack
- Terramera · Canada · North America2020; CAD 4.6MBack
- M2i Life Sciences · France · EuropeSep 2019 · USD 66M; EUR 60M; no later round foundBack
- Provivi · United States · North America2019 · USD 85M; no later round foundBack
No company on the radar in this region yet.
Chinese companies · for reference, never ranked
Facts as published, dated. Uback does not rank or value Chinese companies and no intention can be declared on them.
- Moon Biotech · ChinaStrain bank of more than 260,000 microorganisms (Apr 2025)Series C+ · USD 41.3M · Jul 2024
Listed benchmarks
Not ranked: no intention is possible on a listed company.
- Biotalys · BelgiumEuronext Brussels · BTLS · about USD 105M (Oct 2026)
- Bioceres Crop Solutions · ArgentinaNasdaq · BIOX · about USD 22M (Oct 2026)
- Vittia · BrazilB3 · VITT3 · about USD 90M (Sep 2026)
Sources and method for this segment
Calendar. Global segment rankings are published twice a year. Next edition: February 12, 2027.
Eligibility. At least $1M raised in equity, non-listed company, main activity in this segment (biological inputs). A company appears in one segment only.
Sources. Company announcements, AgFunder News, Global AgInvesting, AgNavigator, AgFeed, Business Wire, CFNews, Tech.eu, The Packer, Fertilizer Daily, company filings and market data for listed companies.